M. Haslbeck

1.1k total citations
61 papers, 712 citations indexed

About

M. Haslbeck is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Haslbeck has authored 61 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Physiology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Haslbeck's work include Heart Rate Variability and Autonomic Control (11 papers), Pain Mechanisms and Treatments (9 papers) and Diet and metabolism studies (7 papers). M. Haslbeck is often cited by papers focused on Heart Rate Variability and Autonomic Control (11 papers), Pain Mechanisms and Treatments (9 papers) and Diet and metabolism studies (7 papers). M. Haslbeck collaborates with scholars based in Germany, Denmark and Estonia. M. Haslbeck's co-authors include Eberhard Standl, Oliver Schnell, H. Mehnert, Daniela Muhr, S. Dresel, B. Neundörfer, Angelika Bierhaus, Claudia Kirsch, Volker W. Rahlfs and Peter Mayr and has published in prestigious journals such as Diabetes Care, Diabetes and Diabetologia.

In The Last Decade

M. Haslbeck

52 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Haslbeck Germany 16 251 199 179 142 97 61 712
C.‐D. AGARDH Sweden 16 618 2.5× 152 0.8× 88 0.5× 140 1.0× 53 0.5× 22 1.0k
Sung Woo Ha South Korea 9 186 0.7× 185 0.9× 354 2.0× 80 0.6× 59 0.6× 19 945
V. Marinescu United States 9 80 0.3× 162 0.8× 148 0.8× 79 0.6× 74 0.8× 16 595
Gabriela A. Eppel Australia 19 124 0.5× 329 1.7× 251 1.4× 117 0.8× 16 0.2× 40 996
Anne Capriotti United States 4 231 0.9× 504 2.5× 203 1.1× 110 0.8× 320 3.3× 4 995
Stephen Podolsky United States 19 418 1.7× 442 2.2× 233 1.3× 176 1.2× 34 0.4× 45 1.4k
S. Gambardella Italy 16 235 0.9× 541 2.7× 224 1.3× 262 1.8× 37 0.4× 41 932
C Le Dévéhat France 14 282 1.1× 52 0.3× 200 1.1× 138 1.0× 32 0.3× 45 621
Kenichi Yamada Japan 12 90 0.4× 83 0.4× 55 0.3× 152 1.1× 90 0.9× 32 694
Toshikazu Kigoshi Japan 13 186 0.7× 437 2.2× 141 0.8× 110 0.8× 47 0.5× 53 760

Countries citing papers authored by M. Haslbeck

Since Specialization
Citations

This map shows the geographic impact of M. Haslbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Haslbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Haslbeck more than expected).

Fields of papers citing papers by M. Haslbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Haslbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Haslbeck. The network helps show where M. Haslbeck may publish in the future.

Co-authorship network of co-authors of M. Haslbeck

This figure shows the co-authorship network connecting the top 25 collaborators of M. Haslbeck. A scholar is included among the top collaborators of M. Haslbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Haslbeck. M. Haslbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haslbeck, M., et al.. (2011). [German national disease management guidelines "diabetic neuropathy". Important implications on clinical practice].. PubMed. 153(49-50). 47–51. 1 indexed citations
2.
Pfützner, A, E Küstner, Thomas Först, et al.. (2009). Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Experimental and Clinical Endocrinology & Diabetes. 104(1). 25–30. 15 indexed citations
3.
Schnell, Oliver, et al.. (2008). Zum diagnostischen Wert des frequenzkorrigierten QT-Intervalls bei langjährigem Typ-I-Diabetes mellitus. DMW - Deutsche Medizinische Wochenschrift. 121(25/26). 819–822.
4.
Haslbeck, M.. (2008). Therapie des Coma diabeticum. DMW - Deutsche Medizinische Wochenschrift. 114(10). 388–392.
5.
Hasche, H, W. E. Bachmann, M. Haslbeck, & H Mehnert. (2008). Hypoglycaemia factitia: Drei Fallbeschreibungen. DMW - Deutsche Medizinische Wochenschrift. 107(16). 625–628. 1 indexed citations
6.
Lautenbacher, Stefan, et al.. (2008). Neuroendokrine Einflüsse auf die Wahrnehmung der Herzaktion*. DMW - Deutsche Medizinische Wochenschrift. 112(39). 1492–1497.
7.
Haslbeck, M., et al.. (2008). Sonographische Größenänderungen der Nieren bei Typ-I-Diabetes als Früherkennungsmethode der diabetischen Nephropathie. Ultraschall in der Medizin - European Journal of Ultrasound. 9(6). 255–259. 2 indexed citations
8.
Pohl, Marcus, et al.. (2008). Glycemic Control in Patients With Type 2 Diabetes Mellitus With a Disease‐Specific Enteral Formula: Stage II of a Randomized, Controlled Multicenter Trial. Journal of Parenteral and Enteral Nutrition. 33(1). 37–49. 40 indexed citations
9.
Neundörfer, B., Ursula Schlötzer‐Schrehardt, Angelika Bierhaus, et al.. (2007). Activation of the RAGE pathway: a general mechanism in the pathogenesis of polyneuropathies?. Neurological Research. 29(1). 103–110. 34 indexed citations
10.
Handschu, René, M. Haslbeck, Arndt Hartmann, et al.. (2005). Mortality prediction in critical care for acute stroke: Severity of illness–score or coma–scale?. Journal of Neurology. 252(10). 1249–1254. 34 indexed citations
11.
Lang, Christian, et al.. (2005). Diabetes and stroke. DMW - Deutsche Medizinische Wochenschrift. 130(6). 291–296. 6 indexed citations
12.
Schleicher, E., Michael Nerlich, M. Haslbeck, et al.. (2002). Formation of Nε-(carboxymethyl)lysine in inflammatory and noninflammatory conditions of nerve and muscle and in inflammatory cells in vitro. International Congress Series. 1245. 53–59.
13.
Haslbeck, M., et al.. (1998). On the prognosis of IDDM patients with large kidneys. Nephrology Dialysis Transplantation. 13(3). 630–634. 46 indexed citations
14.
Schnell, Oliver, Daniela Muhr, Carl‐Martin Kirsch, et al.. (1997). Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. Journal of Diabetes and its Complications. 11(5). 307–313. 15 indexed citations
15.
16.
Schnell, Oliver, et al.. (1995). Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia. 38(11). 1345–1352. 57 indexed citations
17.
Strian, F. & M. Haslbeck. (1994). Behandlung schmerzhafter Diabetesneuropathien. Der Internist. 35. 32–40. 2 indexed citations
18.
Erasmus, Lutz-Peter, et al.. (1994). Visceral perception and gut changes in diabetes mellitus. Neurogastroenterology & Motility. 6(2). 85–94. 3 indexed citations
19.
Bachmann, W. E., I. Böttger, M. Haslbeck, & H. Mehnert. (1979). Extrapancreatic action of sulphonylureas: effect of gliquidone on insulin and glucagon binding to rat liver plasma membranes. European Journal of Clinical Investigation. 9(6). 411–415. 21 indexed citations
20.
Förster, H., M. Haslbeck, & H. Mehnert. (1972). Metabolic Studies Following the Oral Ingestion of Different Doses of Glucose. Diabetes. 21(11). 1102–1108. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.‐D. AGARDH Breakdown of academic impact, for papers by Sung Woo Ha Breakdown of academic impact, for papers by V. Marinescu Breakdown of academic impact, for papers by Gabriela A. Eppel Breakdown of academic impact, for papers by Anne Capriotti Breakdown of academic impact, for papers by Stephen Podolsky Breakdown of academic impact, for papers by S. Gambardella Breakdown of academic impact, for papers by C Le Dévéhat Breakdown of academic impact, for papers by Kenichi Yamada Breakdown of academic impact, for papers by Toshikazu Kigoshi
Rankless by CCL
2026